Cytosorbents Corporation
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY1999 | — | $100.5K | — |
| FY2000 | — | $5.3M | — |
| FY2001 | — | $2.3M | — |
| FY2002 | — | $-4.4M | — |
| FY2003 | — | $-3.9M | — |
| FY2004 | — | $-7.0M | — |
| FY2005 | — | $-9.8M | — |
| FY2006 | — | $2.4M | — |
| FY2007 | — | $-104.3K | — |
| FY2008 | — | $-3.3M | — |
| FY2009 | — | $-5.7M | $1.6M |
| FY2010 | — | $-8.1M | $1.1M |
| FY2011 | — | $-10.1M | $1.2M |
| FY2012 | — | $-11.6M | $1.7M |
| FY2013 | — | $-14.3M | $2.2M |
| FY2014 | — | $6.9M | $3.6M |
| FY2015 | $0 | $9.8M | $5.3M |
| FY2016 | $4.1M | $1.3M | $5.2M |
| FY2017 | $6.0M | $10.3M | $17.3M |
| FY2018 | $9.3M | $16.9M | $22.4M |
| FY2019 | $13.4M | $3.4M | $12.2M |
| FY2020 | $0 | $79.2M | $71.4M |
| FY2021 | — | $62.6M | $52.1M |
| FY2022 | $5.0M | $35.4M | $22.1M |
| FY2023 | $2.5M | $29.9M | $14.1M |
| FY2024 | $14.0M | $19.6M | $3.3M |
| FY2025 | $16.7M | $5.9M | $6.2M |